Publications

Karantanis E, Allen W, Stevermuer TL, Simons AM, O’Sullivan R, Moore KH. The
repeatability of the 24-hour pad test. Int Urogynecol J Pelvic Floor Dysfunct. 2005 Jan-Feb;16(1):63-8;

Simons AM, Yoong WC, Buckland S, Moore KH. Inadequate repeatability of the one-hour
pad test: the need for a new incontinence outcome measure. BJOG. 2001 Mar;108(3):315-9.

Simons AM, Dowell CJ, Bryant CM, Prashar S, Moore KH. Use of the Dowell Bryant
Incontinence Cost Index as a post-treatment outcome measure after non-surgical
therapy. Neurourol Urodyn. 2001;20(1):85-93.

Simons AM, Moore KH, Cragg S. Inadequate repeatability of the 1-hour pad test: the need
for a new incontinence outcome measure. Br J Obstet Gynaecol 2001:108;263-268.

Simons AM, Dowel CJ, Bryant CM, Prashar S, Moore KH. Use of the Dowell Bryant
Incontinence Cost Index as a post-treatment outcome measure after non-surgical
therapy. Neuro Urodyn 2001:20;85-93.

Moore KH, Simons AM, Mukerjee C, Lynch W. The relative incidence of detrusor
Instability and bacterial Cystitis detected on the urodynamic-test day. Br J Urol
2000:85;786-792.

Prashar S, Simons AM, Dowel CJ, Bryant CM, Moore KH. Attitudes to Vaginal/Urethral Touching and Device Placement in Women with Urinary incontinence. Int
Urogynaecol Pelvic Dis 2000:11;4-8.

Dowel CJ, Bryant CM, Moore KH, Simons AM. Calculation of the direct costs of urinary incontinence: the DBICI, a new test instrument. Br J Urol 1999:83;596-606

Moore KH, Simons AM, Dowel CJ, Bryant CM. Efficacy and user acceptability of the
Urethral Occlusive Device in women with urinary incontinence. J Urol
1999:162:464-468.

Simons AM, Dowel C, Bryant C. Visual analogue scale for incontinence impact. Continence J
Aus 1998:4;51.

Simons AM, Moore KH, Cragg S. The repeatability of the standard 1-hour pad test using
Similar ‘natural fill’ bladder volumes. Continence J Aus 1998:4;103.

Prashar S, Moore KH, Anderson P, Louey M, Cragg S, Simons AM, Foote AJ. A randomised
controlled trial of nurse continence advisor Management versus Urogynaecology
management of Conservative continence therapy: benefits and costs. Neuro Urodyn 1998:sept;321.

Simons AM, Hindley J, Gordon H. Twenty-five years of the Obstetric flying squad
in London;Time to be grounded? J Obstet Gynaecol 1997;Nov;51-54..

Simons AM, Mugica-Van Herckenrode C, Rodriguez JA, Maitland N, Anderson M,
Phillips DH, Coleman DV. Demonstration of smoking-related DNA damage in
cervical epithelium and correlation with Human Papillomavirus type 16, using
exfoliative cervical cells. Br J Cancer 1995;71:246-9.

Simons AM, Phillips DH, Coleman DV. Damage to DNA in cervical epithelium
related to smoking tobacco. Br Med J 1993;306:1444-8.

Simons AM, Phillips DH, Coleman DV. DNA adduct assay in cervical epithelium.
Diagnostic Cytol 1994;10:284-8.

Simons AM, Phillips DH, Coleman DV. Smoking-related DNA damage in cervical
epithelium: molecular evidence to support smoking as a cause of cervical cancer.
J Pathol 1993;169(Suppl):14.

Lissauer T, Paterson CM, Simons AM, Beard RW. Evaluation of Computer generated
Neonatal discharge summaries. Arch Dis Child 1991;66(4):433-436.

 

PRESENTATIONS AND ABSTRACTS

  • Aug 2001 – QoL and the TVT procedure
    IUGA Conference, Melbourne, Australia
  • Aug 2000 – Visual Analogue score for Urinary Incontinence
    ICS Conference, Tampere, Finland
  • Aug 99 – Poor accuracy of bladderscan? bvi 2500: test-retest reliability using a test for agreement.
    – The repeatability of the standard one-hour pad test using similar ‘natural fill’ Bladder volumes
    ICS Conference, Denver, USA
  • Sept 98 – “A randomised controlled trial of nurse continence advisor Management
    versus Urogynaecology management of Conservative continence therapy: benefits
    and costs.”
    ICS Conference, Jerusalem, Israel
  • May 98 – “An RCT of Laparoscopic vs Open Burch Colposuspension; An Analysis of
    Surgical Costs.”
  • Australian Urodynamics Society, Sydney.
  • Aug 97 – “Molecular Evidence To Support Smoking As A Cause Of Cervical Cancer;
    Demonstration Of Smoking-Related DNA Damage And It’s Correlation With
    Cervical Intraepithelial Neoplasia [CIN].”
    FIGO 1997, Copenhagen, Denmark.
  • Jan 93 – “Smoking induced DNA Adducts in Cervical Epithelium.”
    Annual meeting of Pathologists of GB & NI, London.
  • Nov 92- “Smoking-related DNA damage in cervical biopsy and exfoliative cervical
    cells; molecular evidence to support smoking as a cause of cervical cancer’
    President’s prize in pathology, Royal Society of medicine, London.
  • Oct 92 – “DNA Adducts assays in Cervico-Vaginal smears.”
    10th International Congress of the International Academy of Pathology &
    10th World Congress of Academic and Environmental Pathology, Madrid,
    Spain.
  • May 92 – “Smoking induced DNA Adducts in Cervical Epithelium.”
    11th Annual International Congress of Cytology, Melbourne, Australia.